Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 9.11% is 219% above its 3-year average of 2.85%, near the high end of its 3-year range (0.00%–9.11%).
As of the fiscal period ended Tuesday, June 30, 2026. 87.84% above its 12-month average of 4.85%.
Reported quarterly debt to assets ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 9.11%.
DEBT TO ASSETS RATIO
9.11%
DEBT TO ASSETS RATIO AVG TTM
4.85%
DEBT TO ASSETS RATIO AVG 3Y
2.85%
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+87.84%
CURRENT VS 3Y AVG
+219.12%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 643 covered companies
CURRENT VS SECTOR MEDIAN
+9008.74%
vs the sector median at left
Citius Oncology, Inc.
Market Cap
$81.02M
Debt to Assets Ratio
9.11%
TTM Avg
4.85%
3Y Avg
2.85%
5Y Avg
N/A
Market Cap
$80.04M
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.46M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.30M
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.14M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Citius Oncology, Inc. (CTOR) | $81.02M | 9.11% | 4.85% | 2.85% | N/A |
| Pulmonx Corporation (LUNG)vs › | $80.04M | 0.49% | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.16M | 0.03% | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $82.66M | 0.03% | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $83.18M | 0.00% | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.46M | 0.02% | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.30M | 0.16% | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.14M | 0.01% | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $77.30M | 0.43% | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.28M | 0.06% | N/A | N/A | N/A |
Debt/Assets
9.1%
Debt/Equity
0.25
Current Ratio
0.73
Interest Coverage
-107.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 9.11% |
| 2026-03-31 | 3.77% |
| 2025-12-31 | 3.46% |
| 2025-09-30 | 3.76% |
| 2025-06-30 | 4.14% |
| 2025-03-31 | 4.16% |
| 2024-12-31 | 4.20% |
| 2024-09-30 | 4.50% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
